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a b s t r a c t
Fullerenols are nanosized water-soluble polyhydroxylated derivatives of fullerenes, specific allotropic form of
carbon, bioactive compounds and perspective pharmaceutical agents. Antioxidant activity of fullerenols was
studied in model solutions of organic and inorganic toxicants of oxidative type – 1,4-benzoquinone and potas-
sium ferricyanide. Two fullerenol preparations were tested: С⁠60О⁠2–4(ОН)⁠20–24 and mixture of two types of
fullerenols С⁠60О⁠2–4(ОН)⁠20–24+С⁠70О⁠2–4(ОН)⁠20–24. Bacteria-based and enzyme-based bioluminescent assays were
used to evaluate a decrease in cellular and biochemical toxicities, respectively. Additionally, the enzyme-based
assay was used for the direct monitoring of efficiency of the oxidative enzymatic processes. The bacteria-based
and enzyme-based assays showed similar peculiarities of the detoxification processes: (1) ultralow concentrations
of fullerenols were active (ca 10⁠–17–10⁠−4 and 10⁠–17–10⁠−⁠5 g/L, respectively), (2) no monotonic dependence of
detoxification efficiency on fullerenol concentrations was observed, and (3) detoxification of organic oxidizer so-
lutions was more effective than that of the inorganic oxidizer. The antioxidant effect of highly diluted fullerenol
solutions on bacterial cells was attributed to hormesis phenomenon; the detoxification was concerned with stim-
ulation of adaptive cellular response under low-dose exposures. Sequence analysis of 16S ribosomal RNA was
carried out; it did not reveal mutations in bacterial DNA. The suggestion was made that hydrophobic mem-
brane-dependent processes are involved to the detoxifying mechanism. Catalytic activity of fullerenol (10⁠−⁠8 g/
L) in NADH-dependent enzymatic reactions was demonstrated and supposed to contribute to adaptive bacterial
response.
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1. Introduction
Fullerenols are bioactive compounds, polyhydroxylated water-solu-
ble derivatives of fullerenes, specific allotropic form of carbon [1]. They
are promising for application in different fields of physics, chemistry,
nanobiotechnology, pharmacology, and medicine [2–5]. Chemical struc-
ture of a representative of fullerenol group, C⁠60(OH)⁠x, is presented in
Fig. 1.
Similar to fullerene C⁠60, fullerenols behave like electron deficient
agents and readily react with electron rich species. This feature makes
fullerenols effective catalysts in chemical and biochemical processes.
Fullerenols are amphiphilic structures: hydroxyl groups provide them
with aqueous solubility while the fragments of fullerene skeleton –
with affinity to lipid structures of cellular membranes [6,7]. The aque
ous solubility of fullerenols depends on the amount of hydroxyl groups
[8].
Due to hydrophilic properties and ability to scavenge free radicals,
fullerenols could provide a serious alternative to the conventional phar-
macological agents in chemotherapy, treatment of neurodegenerative
diseases, and radiobiology [4,9]. A range of fullerenol biological effects
is wide: from cell protection [4,6] to drug transport [10] and neutral-
ization [4]. Biological activity of a series of fullerenols С⁠60(ОН)⁠12–14,
С⁠60(ОН)⁠18–24, С⁠60(ОН)⁠30–38, was studied by Eropkin and co-workers [8].
Fullerenols С⁠60(ОН)⁠18–24 revealed maximal biological activity [3,4,11].
The fullerenols demonstrated antioxidant activity, neutralizing reac-
tive oxygen and nitrogen species [5,11–13]. The antioxidant property
endows fullerenols with ability to treat neurological
Abbreviations: NADH, nicotinamide adenine dinucleotide disodium salt reduced; FMN, flavinmononucleotide; GT, general toxicity; OxT, oxidative toxicity; F-60, fullerenol
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Fig. 1. Hypothetical structure of fullerenol C⁠60(OH)⁠x [1].
diseases [4,5,12,14], to function as radioprotectors [12] or antitumor
agents [15].
Luminous marine bacteria are proper candidates for study the an-
tioxidant activity of fullerenols. The bacteria have been used as a tox-
icity bioassay for several decades [16–20]. The tested parameter here
is luminescence intensity; it can be easily measured instrumentally with
simple physical devices. High rates of bioluminescence registration and
simplicity of the test organism pave the way for simultaneous analyses
of a lot of test-samples under comparable external conditions resulting
in a proper statistical treatment.
Bacterial bioluminescent assays can be based on biological systems
of different complexity – bacteria or their enzymes [17,21,22]. Along
with water-soluble bacterial preparations, the solid preparations of im-
mobilized bacteria and their enzymes have been developed [23–27].
The bacteria-based and enzyme-based assays allow studying mecha-
nisms of toxic effects at cellular and molecular levels, respectively.
First classification of toxic effects in the bioluminescent enzyme system,
based on physicochemical, chemical, and biochemical processes, was
suggested in [28] and developed in [29–32].
Evaluation of antioxidant activity of bioactive compounds is a novel
and prospective field in biosensor application [33,34]. The assay sys-
tems based on luminous marine bacteria and/or their enzyme reactions
are proper candidates in this field. The both bioassays, cellular and en-
zymatic, can be used to evaluate general toxicity of test samples under
conditions of oxidative stress. Additionally, the enzymatic assay is spe-
cific to oxidizers [32]; therefore it can be used for direct monitoring of
oxidative toxicity of solutions. The oxidative toxicity is attributed to re-
dox activity of toxic compounds, while the general toxicity considers, in
a nonadditive way, all interactions of exogenous compounds with the
components of the bioluminescent enzymatic assay system – redox reac-
tions, hydrophobic and polar interactions. Previously [35,36] the gen-
eral and oxidative toxicities of solutions of organic and inorganic oxidiz-
ers, quinones and polyvalent metals, were studied using the biolumines-
cent enzymatic assay. Decrease of both general and oxidative toxicities
under addition of humic substances (products of natural decomposition
of organic matter in soil and bottom sediments) was studied in [37–39].
Description of the enzyme bioluminescent technique to evaluate antiox-
idant activity and toxicity of bioactive compounds is presented in [40].
It should be noted that, similar to reactive oxygen species, active chlo-
rine species can also produce toxic effects [41].
Current work uses fullerenols as bioactive compound models; the
oxidative stress is simulated in solutions of model inorganic and or-
ganic oxidizers – complex salt potassium ferricyanide K⁠3[Fe(СN)⁠6] and
1,4-benzoquinone, respectively. Potassium ferricyanide was chosen be-
cause of its stability in water solutions (in contrast to unclustered iron
salts) and monoelectron oxidative transition Fe⁠3+/Fe⁠2+. The 1,4-benzo-
quinone was chosen being a typical representative of the organic ox-
idizer group. In nature, quinones can appear as a result of oxidative
transformation of various phenols [42,43], i.e. numerous group of hy-
droxylated aromatic compounds, third in the top list of widespread pol
lutants (after metal salts and oil products), and frequent components of
industrial wastewaters.
Current study evaluates changes of general and oxidative toxicities
under addition of fullerenols as detoxifying agents. Cellular and enzy-
matic assays are used for the evaluation the toxicities. A wide range
of the fullerenol concentrations is tested, including ultralow concentra-
tions. Detoxifying activities of two types of fullerenols (С⁠60О⁠2–4(ОН)⁠20–24
and a mixture of fullerenols С⁠60О⁠2–4(ОН)⁠20–24+С⁠70О⁠2–4(ОН)⁠20–24) are
under investigation. Additionally, our work focuses on chemical and
biochemical processes taking place in the course of detoxification of the
oxidizer solutions; the rates of chemical and biochemical processes in
oxidizer +fullerenol solutions are analyzed.
The paper describes the results in the following sequence: Section
3.1 presents the evaluation of proper conditions for toxicity measure-
ments focusing on fullerenol and oxidizer concentrations; mutagenicity
of the oxidizer solutions is tested; Section 3.2 studies a response of bac-
terial cells to the fullerenol exposure in the oxidizer solutions; changes
of general toxicity are determined; Section 3.3 studies the effects of the
fullerenols on the bioluminescent enzymatic system; changes of general
and oxidative toxicities are evaluated; rates of chemical and biochemi-
cal reactions are determined. Section Discussion considers peculiarities
of fullerenol detoxifying effect (4.1) and presents speculations on mech-
anism of biological activity of highly diluted fullerenol solutions (4.2).
2. Materials and methods
2.1. Reagents and equipment
Toxicity of water solutions of model oxidizers K⁠3[Fe(СN)⁠6] (potas-
sium ferricyanide) and 1,4-benzoquinone was assessed using two biolu-
minescent assay systems: (1) bacterial assay, i.e. Microbiosensor 677F,
based on the lyophilized luminous bacteria Photobacterium phosphoreum,
and (2) enzymatic assay, i.e. the preparation based on the coupled en-
zyme system NADH: FMN-oxidoreductase from Vibrio fischeri (0.15 a.u.)
and luciferase from Photobacterium leiognathi, 0.5 mg/ml [44]. All the
biological preparations were produced at the Institute of Biophysics
SB RAS (Krasnoyarsk, Russia). The chemicals used were: NADH from
ICN, USA; FMN, and tetradecanal from SERVA, Germany; potassium fer-
ricyanide of analytical grade, Khimreactiv, Russia; 1,4-benzoquinone,
Aldrich, USA.
The enzymatic system includes two coupled reactions:
(1)
(2)
To construct the enzyme system, 0.1 mg/ml enzyme preparation,
5∙10⁠-4 M FMN, 4∙10⁠−4 M NADH, and 0.002% tetradecanal solutions
were used. The assay was performed in a 0.05 M phosphate buffer (pH
6.8) at room temperature.
Fullerenes were synthesized by carbon helium high-frequency arc
plasma at atmospheric pressure [45,46]. The fullerene content in carbon
soot was about 12.6%. Fullerene mixture was extracted with toluene,
and the individual C⁠60 fullerene was separated by liquid chromatogra-
phy with turbostratic graphite (with interplanar distance 3.42 Å) as a
stationary phase and toluene/hexane (4:6) mixture as a mobile phase.
Fullerenol С⁠60О⁠2–4(ОН)⁠20–24 (F-60) and mixture of fullerenols
С⁠60О⁠2–4(ОН)⁠20–24 and С⁠70О⁠2–4(ОН)⁠20–24 (with 60% of F-60) (F-60,70)
were produced by fullerene hydroxylation in nitric acid followed by the
hydrolysis of the polynitrofullerenes [3,46,47]. The fullerenol prepara-
tions were characterized with IR and photoelectron spectroscopies [48].
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Measurements of bioluminescent intensity were carried out with bi-
oluminometers BLM-3606 (Nauka Special Design Bureau, Russia) and
TriStar LB 941 (Berthold Technologies, Germany). Optical density of so-
lutions was measured by double-beam spectrophotometer UVIKON-943
(KONTRON Instruments, Italy).
2.2. Experimental data processing
Effects of fullerenols on bioluminescence of bacterial and enzyme as-
say systems were evaluated by relative bioluminescent intensity, :
(3)
Here, I⁠contr and I⁠F are maximal bioluminescent intensities in the ab-
sence and presence of fullerenols, respectively.
General Toxicity (GT) of the oxidizer solutions was evaluated by a
similar way (Eq. (3a)), i.e. with relative bioluminescent intensity, :
(3a)
Here, and are maximal bioluminescent intensities in the
absence and presence of oxidizers, respectively.
Effective concentrations of oxidizers decreasing bioluminescent in-
tensity by 50% ( =0.5), EC⁠50, were determined.
To characterize the changes of General Toxicity (GT) under the ex-
posure to fullerenols, both bioluminescent assays, bacterial and enzy-
matic, were applied. The detoxification coefficients, D⁠GT, were calcu-
lated as:
(4)
where and are relative bioluminescent intensities in oxi
Fig. 2. Bioluminescent kinetics in solution of a model oxidizer (Ox) and fullerenol (F).
dizer solutions at EC⁠50, in the presence and absence of fullerenols, re-
spectively. Values of D⁠GT were determined at different fullerenol concen-
trations.
To characterize the Oxidative Toxicity (OxT) of oxidizer solutions,
the bioluminescent enzymatic assay was used; an example of the biolu-
minescent kinetics is schematically presented in Fig. 2. Bioluminescence
delay period in oxidizer solutions, (T⁠0.5)⁠ox, is indicated in this Figure.
Changes of Oxidative Toxicity (OxT) under fullerenol exposure were
characterized with detoxification coefficients, D⁠OxT:
(5)
here, (T⁠0.5)⁠Оx+F and (T⁠0.5)⁠Оx are bioluminescence delay periods in ox-
idizer solutions in the presence and absence of fullerenols, respectively.
Values of D⁠OxT were determined at different fullerenol concentrations.
Values of D⁠GT>1 and D⁠OxT >1 showed a decrease of GT and OxT in
oxidizer solutions under the exposure to fullerenols, i.e. detoxification
of the oxidizer solutions. Values of D⁠GT ≈1 and D⁠OxT ≈1 showed the ab-
sence of the fullerenol effects.
Values of SD for D⁠GT and D⁠OxT did not exceed 0.1. The data for the
calculations of D⁠GT or D⁠OxT were obtained in three parallel experiments
with five samplings for all fullerenol and control solutions. Values of SD
for NADH oxidation rates were 10⁠–8 М/min; the data for the rate calcu-
lations were obtained in three experiments with five samplings in each
of them.
2.3. Sequence analysis
Mutagenic effect of the oxidizer solutions was examined using se-
quence analysis of the 16S ribosomal RNA gene of P.Phosphoreum. This
gene was chosen for genetic analysis as a model for evaluating nonspe-
cific DNA damage. The analysis was performed on the samples of bac-
terial suspensions exposed to 1,4-benzoquinone (2 10⁠−⁠7M and 10⁠−6M);
the results were compared to those obtained on the control bacterial sus-
pensions.
3. Results
3.1. Evaluation of fullerenol and oxidizer concentrations for toxicity
measurements
3.1.1. Influence of fullerenols on bioluminescent intensity
Fig. 3 presents a dependence of bioluminescent intensity ( , Eq.
(3)) of luminous bacterial and enzyme assay system on concentrations
of fullerenol F-60. As is evident from this Figure, the fullerenol sup-
presses bioluminescence of the bacterial and enzymatic systems at con
Fig. 3. Bioluminescent intensity at different concentrations of F-60 in bacterial (A) and enzymatic (B) systems.
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centrations >10⁠-2 g/L and >5∙10⁠-3 g/L, respectively. Similar results
were obtained for the other fullerenol preparation, F-60,70.
The suppression of bioluminescent intensity is an evidence of
fullerenol toxic effect; it is concerned with inhibition of membrane and
intracellular processes (for bacterial cells) or chemical and biochemical
reactions (for enzyme system). Additional reasons for the biolumines-
cence suppression can be: the effect of “optic filter” as a result of bio-
luminescence absorption/reabsorption [17] and “concentration quench-
ing” resulted from collisional intermolecular interactions. The latter
processes are concerned with peculiarities of the luminescence registra-
tion in solutions and do not contribute to toxic effects.
Basing on the experiments described, we chose the range of
fullerenol concentrations for further experiments (<10⁠−⁠4 g/L) provid-
ing the absence of the fullerenol inhibiting effect. The fullerenol concen-
trations varied in this range to decrease General Toxicity (GT) and Ox-
idative Toxicity (OxT) in solutions of oxidizers (organic and inorganic)
as described below in Sections 3.2 and 3.3.
3.1.2. Oxidizers: effective concentrations (EC⁠50) and mutagenicity
Effective concentrations of oxidizers decreasing bioluminescent in-
tensity by 50% ( =0.5), EC⁠50, were determined with bacterial and
enzymatic bioluminescent assays. The EC⁠50 values of 1,4-benzoquinone
were 2.5∙10⁠-7 M and 10⁠−⁠4 M for bacterial and enzymatic assays, respec-
tively, while the EC⁠50 values of potassium ferricyanide were 4∙10⁠−2 M
and 2·10⁠−⁠4 M. Lower EC⁠50 values of 1,4-benzoquinone reveal higher tox-
icity of this oxidizer. This result is supported by the differences in stan-
dard redox potentials (0.7 V and 0.36 V at neutral pH for 1,4-benzo-
quinone and potassium ferricyanide, respectively) [49] and hydropho-
bic characteristics of the oxidizers.
The ЕС⁠50 values were applied in further experiments to monitor
changes of General Toxicity (GT) in oxidizer solutions under addition of
fullerenols, as described in Sections 3.2 and 3.3.1 for bacterial and en-
zymatic assays, respectively.
Mutagenic effect of organic oxidizer solutions (1,4-benzoquinone,
2.5 10⁠−7M and 10⁠−6 M) was examined using sequence analysis of the
16S ribosomal RNA gene; the results were compared to those obtained
on the control bacterial suspension. No changes in the analyzed gene se-
quence were found under the conditions of the experiment. Hence, the
analysis did not reveal any mutations in DNA of the bacteria exposed to
the oxidizer.
3.2. Bacterial response to the fullerenol exposure in solutions of oxidizers
Detoxifying ability of fullerenols was studied using the bacte-
ria-based assay. Bioluminescent intensity of the bacteria was measured
in solutions of model oxidizers (1,4-benzoquinone and potassium fer-
ricyanide) at ЕС⁠50 in the absence and presence of fullerenols F-60 and
F-60,70. Concentrations of the fullerenols varied in a wide range as
shown in Fig. 4. Detoxification coefficients D⁠GT were calculated accord-
ing to Eq. (4).
Fig. 4 shows that 1,4-benzoquinone solutions were detoxified
(D⁠GT>1) in the concentration ranges of 10⁠–17–10⁠−8 and 10⁠–17−10⁠−⁠4 g/
L for F-60 and F-60,70, respectively. Maximal values of D⁠GT were about
1.5 and 1.8, respectively. In solutions of potassium ferricyanide, the val-
ues of D⁠GT were lower: they are not more than 1.3 for F-60,70 and close
to “1” at all F-60 concentrations. No monotonic dependencies of D⁠GT on
fullerenol concentrations were observed in all cases.
3.3. Effects of fullerenols on enzymatic processes
This section presents fullerenol effects on the bioluminescent system
of coupled enzymatic reactions (reactions (1), (2)). It studies: (1) enzy-
matic activity characterized by bioluminescent intensity of the coupled
enzymatic system (I, Figs. 2), (2) redox properties of the enzyme sys
Fig. 4. Detoxification coefficients D⁠GT vs. concentration of fullerenols F-60 (A) and F-60,70
(B) in solutions of 1,4-benzoquinone (2.5∙10⁠-7 M) and potassium ferricyanide (4·10⁠-2 М).
Bacteria-based assay.
tem evaluated by the bioluminescence induction period (T⁠0.5, Figs. 2),
and (3) rates of oxidation of NADH, endogenous reducer, a low-molec-
ular component of the bioluminescent enzyme system. Changes of these
characteristics are presented in Sections 3.3.1, 3.3.2, and 3.3.3, respec-
tively.
3.3.1. Changes of enzymatic activity under the action of fullerenols in
oxidizer solutions
Bioluminescent intensity was measured in solutions of oxidizers in
the absence and presence of fullerenols: I⁠ox and I⁠ox+F, respectively, Fig.
2. Detoxification coefficients D⁠GT calculated with Eq. (4), are presented
in Fig. 5. Fig. 5A demonstrates detoxifying effect of F-60 (D⁠GT >1) in
oxidizer solutions in at different fullerenol concentrations. Lower detox-
ification coefficients D⁠GT were found under exposure to F-60,70, Fig. 5B.
It is evident that D⁠GT values in solutions of organic oxidizer, 1,4-ben-
zoquinone, are higher than those of inorganic oxidizer, potassium ferri-
cyanide. Probably, hydrophobic properties of the solution components
(fullerenol+oxidizer) are critical for the enzymatic process, similar to
the cellular process.
3.3.2. Changes of redox properties of the bioluminescent enzyme system in
oxidizer+fullerenol solutions
Bioluminescent kinetics of the enzymatic system was studied in so-
lutions of model organic and inorganic oxidizers. Induction periods
were measured in the absence and presence of fullerenols: (T⁠0.5)⁠ox and
(T⁠0.5)⁠ox+F, respectively, Fig. 2. Detoxification coefficients D⁠OxT were cal-
culated with Eq. (5).
Fig. 6 demonstrates the dependences of D⁠OxT on fullerenol concentra-
tions. Detoxification coefficients D⁠OxT in the solutions of organic oxidizer
1,4-benzoquinone (Fig. 6A,B) were found to be higher than these in fer-
ricyanide solutions; they reached up to “2” in the cases of both F-60 and
F-60,70. These data demonstrate an effective decrease of oxidative toxi-
city in the range of ca 10⁠–12–10⁠-6 g/L for F-60, and ca 10⁠–16–10⁠-4 g/L for
F-60,70.
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Fig. 5. Detoxification coefficients D⁠GT vs. concentration of fullerenols F-60 (A) and F-60,70
(B) in solutions of 1,4-benzoquinone (10⁠−4 M) and potassium ferricyanide (2·10⁠−4 М). En-
zyme-based assay.
Fig. 6. Detoxification coefficients D⁠OxT vs. concentration of fullerenols F-60 (A) and
F-60,70 (B) in solutions of 1,4-benzoquinone (10⁠−4 M) and potassium ferricyanide
(2·10⁠−4 М). Enzyme-based assay.
3.3.3. Reaction rates in enzymatic assay system in solutions of oxidizers
and fullerenols
The rates of NADH oxidation were studied in the presence and ab-
sence of fullerenol F-60, in enzymatic and nonenzymatic processes,
Table 1.
Table 1
Rates of NADH oxidation in the absence (V) and presence (V⁠F) of fullerenol – F-60,
С⁠NADH=1.6∙10⁠–4 М, С⁠F-60=10⁠–8 g/L. C⁠FMN=5.4∙10⁠–5 М, E – enzyme preparation. Registra-
tion wavelength 340 nm. SD for V and V⁠F was 10⁠–8 М/min.
No Components of solution V·10⁠8, М/min
V V⁠F V⁠F - V
Nonenzymatic processes
1 NADH (auto-oxidation) 6 10 4
2 NADH+FMN 32 32 0
Enzymatic processes
1Е NADH+Е 4 9 5
2Е NADH+FMN+Е 317 374 57
The rates of NADH auto-oxidation in the absence (No. 1) and pres-
ence (No. 1E) of the enzymes are presented in the Table 1. These val-
ues are close to those determined previously [36,39]. The data show
that the addition of F-60 to NADH solutions increases the auto-oxidation
rates by 4∙10⁠−8 and 5∙10⁠−⁠8 М/min, respectively.
Reactions No. (2) and 2E (Table 1) present endogenous processes in
the bioluminescent assay system, i.e. nonenzymatic and enzymatic re-
dox reactions of the endogenous reducer and oxidizer (NADH and FMN,
respectively, reaction (1), Section 2.1). Addition of F-60 increased the
rate of the enzymatic reaction by 57∙10⁠−8 М/min, Table 1. Similar re-
sults were obtained with fullerenol F-60,70.
Light-absorption spectra of oxidizer solutions (EC⁠50, Section 3.1.2)
were studied under exposure to fullerenols of different concentrations:
10⁠–17−10⁠−4 g/L. No changes in oxidizer concentrations were observed
during the 4-h exposure.
4. Discussion
4.1. Peculiarities of fullerenol detoxifying effect
Figs. 4–6 demonstrate that D⁠GT and D⁠OxT exceed “1” in a wide
range of fullerenol concentrations, revealing detoxification ability of
fullerenols in oxidizer solutions. Both cellular and enzymatic assays
demonstrate the detoxifying activity of the fullerenols. Three peculiar-
ities of the fullerenol detoxifying effect are evident from these exper-
iments: (1) highly diluted fullerenol solutions were active, (2) no mo-
notonic dependencies of D⁠GT or D⁠OxT on fullerenol concentrations were
observed, and (3) detoxification of organic oxidizer solutions was more
effective.
The NADH, organic reducer, is a component of a lot of biochemical
reactions, including reaction (1) in the bioluminescent system of cou-
pled enzymatic reactions (Section 2.1). The change of rate of NADH ox-
idation serves as an indicator of intensification (or slowdown) of redox
processes in the assay system. Section 3.3.3 studied rates of NADH ox-
idation in the absence and presence of fullerenol (10⁠−8 g/L), in enzy-
matic and nonenzymatic processes, Table 1. Acceleration of auto-oxida-
tion processes (No. 1 and 1E, Table 1) by the fullerenol was found. This
result shows that the fullerenol stimulates an oxidation of the endoge-
nous reducer, NADH, withdrawing it from the biochemical process, de-
creasing the bioluminescent intensity in accordance with reactions (1)
and (2) (Section 2.1), and contributing to toxicity increase (D⁠GT<1).
On the other hand, fullerenol increased the rate of the enzymatic re-
dox reaction of endogenous reducer and endogenous oxidizer (NADH
and FMN, respectively, reaction (1), Section 2.1) by 57∙10⁠-8 М/min
(No. 2E, Table 1). So, the experiments demonstrate that fullerenols are
able to increase toxicity of aqueous solutions by acceleration of NADH
auto-oxidation, or decrease the toxicity by acceleration of endogenous
NADH-dependent biochemical processes. In both cases, fullerenol in
highly diluted solutions (10⁠–8 g/L, corresponding to ca 10⁠–11 M) can be
considered as a catalyzer of the redox reactions.
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Light-absorption measurements in oxidizer solutions showed inde-
pendence of 1,4-benzoquinone or ferricyanide concentrations on the ex-
posure to fullerenol and, hence, did not confirm the neutralization of
the oxidizers in the solutions, outside the bioassay systems.
All the peculiar experimental results suggest a specific mechanism of
the fullerenol biological influence.
4.2. On mechanism of antioxidant effects in highly diluted solutions of
fullerenols
Ultralow bioactive concentrations of fullerenols are a subject of a
special interest. Previous sections showed that antioxidant effects of the
fullerenols take place within ca 10⁠–17–10⁠−⁠4 and 10⁠–17–10⁠−⁠5 g/L for bac-
teria-based and enzyme-based assays, respectively. The active concen-
trations may correspond to several tens of fullerenol molecules per liter.
Activation of vital functions of various organisms by low-intensive
exposures is a well-known effect, common to all living organisms. It is
attributed to triggering of cell defense response under the influence of
low concentrations of toxins, low dose radiation, and other stressors. It
is known that low doses of bioactive substances can serve as effective
drugs [50–52].
Generally, low-intensive exposures are described in terms of horme-
sis phenomenon. “Hormesis” is a term for “a generally favorable biolog-
ical response to low exposures to toxins and other stressors.” “It is char-
acterized by low-dose stimulation and high-dose inhibition, resulting in
either a J-shaped or an inverted U-shaped dose response” [51,53–56].
The rapid and extensive exponential growth of hormesis citations in the
biomedical community takes place for the last two decades [55]. Ev-
idence emerged that hormesis is highly generalizable, independent on
biological model or endpoint measured, inducing agent and level of bi-
ological organization (e.g. cell, organ, organism). The hormesis mecha-
nism is not understood yet and still lacks strong experimental support,
which leads to uncertainty as to the exact underlying causes of horme-
sis [57]. There exist two models explaining mechanism of hormesis;
they consider the adaptive response as related with DNA damage or cell
membrane processes [50,58–61].
In our previous studies, we demonstrated a positive response of lu-
minous bacteria to low-dose radiation exposure. The results of a series
of investigations were summarized in a review [62]. Independency of
the bacterial luminescent response on active concentration of beta-emit-
ting radionuclide tritium was demonstrated for intact and lyophilized
bacteria in a wide radioactivity interval: 10⁠-4-200 MBq/L [22]. Similar
low-dose radiation effects, current study showed (a) positive response
of the luminous bacteria to fullerenol exposure and (b) absence of lin-
ear dose-effect dependencies: the bacterial and enzyme luminescent re-
sponses did not depend on fullerenol concentrations in a wide concen-
tration interval: ca 10⁠–17–10⁠−⁠4 and 10⁠–17–10⁠−⁠5 g/L, respectively.
Biological efficiency of ultralow concentrations of hydrated
fullerenes was determined and discussed earlier in [63,64]. This effect
was attributed to fullerene ability to adjust dynamic structure of aque-
ous media and to “regulate redox processes (especially those involving
oxygen) in aqueous systems”. Earlier [65], a role of aqueous medium in
antiradical activity of fullerenols was discussed. According to [62,66],
reactive oxygen species in aqueous media might contribute to bacterial
bioluminescence activation under low-dose exposures.
Sequence analysis did not reveal any mutagenic effect of the oxi-
dizer solutions under the conditions of the experiments. Therefore, the
low-concentration fullerenol effect might be due to “nongenetic” mech-
anism of the cellular response. The results of this study might be in-
terpreted using the novel “exposome” concept, that complements the
genome and encompasses the totality of environmental (i.e. non-ge-
netic) exposures [67].
The difference in effects of fullerenols in solutions of organic and
inorganic oxidizers might be concerned with membrane processes in
the luminous bacteria. Probably, the combination of amphiphilic com-
pounds (1,4-benzoquinon+fullerenol) in water solutions promotes
membrane processes resulting in the intensification of protecting meta-
bolic response of the bacterial cells. Changes in structural organization
and fluidity of lipid bilayers in hydrophobic parts of a membrane by
F-60 were previously reported in [68]. In our resent experiments under
conditions excluding penetration of radionuclide tritium to the bacterial
cells [69], a preference of membrane process for the bacterial biolumi-
nescence activation was proved.
Hence, the low-concentration antioxidant effects of fullerenols on
bacterial cells can be attributed to hormesis phenomenon, while the in-
tensification of biochemical reactions is explained in terms of fullerenol
catalytic activity. Cellular and enzymatic bioluminescent assays showed
that solutions of organic oxidizer are detoxified more effectively than
those of inorganic oxidizer, indicating the importance of hydrophobic
interactions in the detoxification mechanism.
5. Conclusions
The study considers antioxidant properties of bioactive compounds,
fullerenols – nanosized water-soluble derivatives of fullerenes, specific
allotropic form of carbon. Two fullerenol preparations were tested:
С⁠60О⁠2–4(ОН)⁠20–24 and mixture of two types of fullerenols
С⁠60О⁠2–4(ОН)⁠20–24+С⁠70О⁠2–4(ОН)⁠20–24. Fundamental and applied aspects
of the fullerenol antioxidant activity were under consideration.
The study promotes application of bioluminescent assays to evaluate
detoxifying activity of bioactive compounds, with fullerenols taken as
an example. Bacteria-based assay was used to demonstrate a decrease in
cellular toxicity, while the enzyme-based assay – in biochemical toxic-
ity. Additionally, the enzyme-based assay was used for the direct moni-
toring of the efficiency of oxidative enzymatic processes.
Bacteria-based and enzyme-based assays have demonstrated similar
peculiarities of the detoxification processes: (1) ultralow concentrations
of fullerenols were active (ca 10⁠–17–10⁠−⁠4 and 10⁠–17–10⁠−⁠5 g/L, respec-
tively), (2) no monotonic dependencies of detoxification efficiency on
fullerenol concentrations were observed, and (3) detoxification of or-
ganic oxidizer solutions was more effective than that of the inorganic
oxidizer. First and second peculiarities attribute the antioxidant effects
of fullerenols to hormesis phenomenon, which is generally considered
as a basis for biological adaptive response. Since the sequence analysis
of 16S ribosomal RNA gene did not reveal any mutagenic effects of oxi-
dizer solutions, the results support the concept of a “nongenetic” mech-
anism of the cellular response to the low-concentration fullerenol expo-
sure.
Higher detoxification efficiency in solutions of the organic oxidizer
supports a suggestion on involving hydrophobic (probably mem-
brane-dependent) processes to the detoxification mechanism.
Catalytic activity of fullerenol (10⁠−⁠8 g/L) in NADH-dependent en-
zymatic reactions was demonstrated and supposed to contribute to the
adaptive bacterial response.
Current work elaborates physicochemical, biochemical and cellular
basis for bioluminescence-based sensors aimed at evaluation of antiox-
idant activity of bioactive compounds. The study develops application
of luminous marine bacteria and their enzyme reactions for the antioxi-
dant activity monitoring. High potential of the bioluminescence systems
for studying the biological activity in ultra-diluted solutions is demon-
strated. The bioluminescent bacteria- and enzyme-based assays are suit-
able for low-dose effect evaluation due to simplicity and high rates of
bioluminescence measurements. These properties ensure higher reliabil-
ity of the biological measurements.
Apart from the quantitative evaluation, molecular mechanisms of
adaptive response in the bacterial cells should be studied in further ex
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periments using a number of methods applicable for intracellular
processes: from membrane penetrability to gene regulation, enzyme ac-
tivity, ATP consumption and crystallinity of intracellular macrocompo-
nents.
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